Anixa CAR-T Breakthrough Highlighted at SCTR 2026
SAN JOSE, Calif., Feb. 23, 2026 — Anixa Biosciences announced that immunology leader Jose Conejo-Garcia, M.D., Ph.D., will keynote...
Immuno-Oncology
Analgesic Allergy Labels Tied to Maternal Risks
MILWAUKEE, Feb. 21, 2026 — New research presented at the 2026 Annual Meeting of the American Academy of Allergy,...
ImmunityBio Expands ANKTIVA Access in Saudi Arabia
SAN DIEGO & RIYADH — February 20, 2026 — Immunotherapy innovator ImmunityBio has announced a strategic partnership with regional...
FDA Clears IND for CS2009 Trispecific Antibody Trial
SUZHOU, China, Feb. 15, 2026 — CStone Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Investigational...
Merck Advances GU Cancer Care With New ASCO Data
RAHWAY, N.J., Feb. 12, 2026 — Merck & Co. announced the presentation of extensive new clinical data in bladder...
SENTI-202 AML Cell Therapy Completes Phase 1 Enrollment
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 — Senti Biosciences announced the completion of patient enrollment in its Phase...
Phio Pharmaceuticals Highlights siRNA Oncology Program at DealFlow
KING OF PRUSSIA, PENNSYLVANIA | January 26, 2026 — Phio Pharmaceuticals has announced its participation in the Third Annual...
Janux and BMS Partner on Tumor-Activated Cancer Therapy
SAN DIEGO, January 22, 2026 — Janux Therapeutics announced a collaboration and exclusive worldwide license agreement with Bristol Myers...
BioVaxys Shows Durable Benefit in Ovarian Cancer Trial
Vancouver, British Columbia | January 20, 2026 — BioVaxys Technology Corp. reported positive Phase 1B/2 clinical results from its...
Alligator to Present New Mitazalimab Data at ASCO GI 2026
LUND, Sweden | January 9, 2026 — Alligator Bioscience announced that new clinical data from its Phase 1b/2 OPTIMIZE-1...